Robert E. Landry - 31 Aug 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Finance CFO
Signature
/s/** Robert E. Landry
Issuer symbol
REGN
Transactions as of
31 Aug 2021
Net transactions value
-$63,333
Form type
4
Filing time
01 Sep 2021, 16:05:39 UTC
Previous filing
10 Aug 2021
Next filing
18 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $555,670 +1,000 +3.9% $555.67 26,903 31 Aug 2021 Direct
transaction REGN Common Stock Tax liability $619,003 -917 -3.4% $675.03 25,986 31 Aug 2021 Direct
holding REGN Common Stock 229 31 Aug 2021 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,000 -20% $0.000000 4,000 31 Aug 2021 Common Stock 1,000 $555.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option award vests in four equal annual installments, commencing one year after the date of grant.